Literature DB >> 20531976

A spatially varying two-sample recombinant coalescent, with applications to HIV escape response.

Alexander Braunstein1, Shane T Jensen, Zhi Wei, Jon D McAuliffe.   

Abstract

Statistical evolutionary models provide an important mechanism for describing and understanding the escape response of a viral population under a particular therapy. We present a new hierarchical model that incorporates spatially varying mutation and recombination rates at the nucleotide level. It also maintains separate parameters for treatment and control groups, which allows us to estimate treatment effects explicitly. We use the model to investigate the sequence evolution of HIV populations exposed to a recently developed antisense gene therapy, as well as a more conventional drug therapy. The detection of biologically relevant and plausible signals in both therapy studies demonstrates the effectiveness of the method.

Year:  2008        PMID: 20531976      PMCID: PMC2881484     

Source DB:  PubMed          Journal:  Adv Neural Inf Process Syst        ISSN: 1049-5258


  8 in total

1.  Models of sequence evolution for DNA sequences containing gaps.

Authors:  G McGuire; M C Denham; D J Balding
Journal:  Mol Biol Evol       Date:  2001-04       Impact factor: 16.240

2.  Consequences of recombination on traditional phylogenetic analysis.

Authors:  M H Schierup; J Hein
Journal:  Genetics       Date:  2000-10       Impact factor: 4.562

3.  Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data.

Authors:  Na Li; Matthew Stephens
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

4.  Estimating diversifying selection and functional constraint in the presence of recombination.

Authors:  Daniel J Wilson; Gilean McVean
Journal:  Genetics       Date:  2005-12-30       Impact factor: 4.562

5.  Clinical resistance to enfuvirtide does not affect susceptibility of human immunodeficiency virus type 1 to other classes of entry inhibitors.

Authors:  Neelanjana Ray; Jessamina E Harrison; Leslie A Blackburn; Jeffrey N Martin; Steven G Deeks; Robert W Doms
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

6.  A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion.

Authors:  C Wild; T Greenwell; T Matthews
Journal:  AIDS Res Hum Retroviruses       Date:  1993-11       Impact factor: 2.205

7.  Properties of a neutral allele model with intragenic recombination.

Authors:  R R Hudson
Journal:  Theor Popul Biol       Date:  1983-04       Impact factor: 1.570

8.  Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.

Authors:  Xiaobin Lu; Qiao Yu; Gwendolyn K Binder; Ziping Chen; Tatiana Slepushkina; John Rossi; Boro Dropulic
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

  8 in total
  1 in total

1.  Incorporating External Information in Tissue Subtyping: A Topic Modeling Approach.

Authors:  Ardavan Saeedi; Payman Yadollahpour; Sumedha Singla; Brian Pollack; William Wells; Frank Sciurba; Kayhan Batmanghelich
Journal:  Proc Mach Learn Res       Date:  2021
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.